Results 121 to 130 of about 2,204,237 (310)

Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxis

open access: yesCancer Immunology and Immunotherapy, 2021
M. He   +11 more
semanticscholar   +1 more source

Antiviral regulator TRIM25 as a prognostic marker of better survival in Merkel cell carcinoma: Association with MCPyV status

open access: yesInternational Journal of Cancer, EarlyView.
What's New? TRIM25 is known for its role in antiviral immunity and association with poor prognosis in various cancers. This study reveals an association between high TRIM25 expression and Merkel cell polyomavirus positivity in Merkel cell carcinoma.
Klaus W. Fagerstedt   +6 more
wiley   +1 more source

Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections. [PDF]

open access: yes, 2018
The CRISPR/Cas9 system has been applied in the genome editing and disruption of latent infections for herpesviruses such as the herpes simplex virus, Epstein⁻Barr virus, cytomegalovirus, and Kaposi's sarcoma-associated herpesvirus.
Chen, Yuan-Chuan   +3 more
core   +2 more sources

Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers

open access: yesVirology Journal, 2011
Background and AimsELISA is still used as primary test for diagnosis HBV disease. However, ELISA-positive patients were marked as HBV inactive after confirmation with PCR and vice versa.
B. Ijaz   +4 more
semanticscholar   +1 more source

Epigenetic Regulation in the Pathogenesis of Renal Inflammation: Insights and Therapeutic Potentials

open access: yesiNew Medicine, EarlyView.
ABSTRACT Renal inflammation is a common pathological process in various kidney diseases, often initiated by factors such as toxins, ischemia, or autoimmune reactions. This inflammatory response can result in structural damage and a rapid decline in renal function.
Yu‐Hang Dong   +5 more
wiley   +1 more source

Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.

open access: yesWorld Journal of Gastroenterology, 2011
AIM To analyze the antiviral mechanism of Epigallocatechin gallate (EGCG) against hepatitis B virus (HBV) replication. METHODS In this research, the HBV-replicating cell line HepG2.117 was used to investigate the antiviral mechanism of EGCG ...
Wei He   +4 more
semanticscholar   +1 more source

Dupilumab Treatment in Pemphigus: A Report of Three Cases and Literature Review

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Pemphigus vulgaris (PV) and foliaceus (PF) are rare autoimmune blistering diseases traditionally treated with systemic corticosteroids, immunosuppressants, intravenous immunoglobulins, and rituximab. Nonetheless, a subset of patients remains refractory or has contraindications to these conventional therapies.
José Javier Mateos Rico   +5 more
wiley   +1 more source

产妇血清HBV DNA含量对乳汁和新生儿血清HBV DNA浓度的影响

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2010
【目的】 探讨乙型肝炎病毒携带产妇血清HBV DNA含量对乳汁和新生儿血清中HBV DNA含量的影响,以指导孕期处理和母乳喂养。【方法】 选择乙型肝炎病毒携带产妇145例,采用荧光定量聚合酶链反应(FQ-PCR)技术对产妇血清,母乳和新生儿血清HBV DNA进行检测,并将产妇血清HBV DNA浓度分3级,分析产妇血清不同HBV DNA浓度级对乳汁及新生儿血清HBV DNA浓度的影响。【结果】 血清HBV DNA < 500 copies/mL的产妇74例,乳汁中检出HBV DNA阳性为零 ...
doaj  

Measuring HBsAg and HBV DNA Levels in Cilegon [PDF]

open access: yes, 2009
Background: Implication of measuring HBsAg level is still not recognized well. The aim of this study to recognize the correlation of serum HBsAg level and serum HBV DNA level between in HBeAg positive patients and HBeAg negative patients.
Budihusodo, U. (Unggul)   +2 more
core   +1 more source

From HBV to MASLD Cirrhosis: Mechanistic Insights and Therapeutic Strategies

open access: yesPortal Hypertension &Cirrhosis, EarlyView.
This review examines the epidemiological shift from hepatitis B virus (HBV) to metabolic dysfunction‐associated steatotic liver disease (MASLD) as the leading cause of cirrhosis globally. It highlights the distinct pathogenic mechanisms between HBV and MASLD cirrhosis and discusses evolving diagnostic tools and therapeutic strategies tailored to the ...
Hanqi Yu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy